What is AtriCure's R&D?

AtriCure (ATRC) reported R&D of $26.4M in Q2 2026.

How has AtriCure's R&D changed year-over-year?

AtriCure's R&D decreased by 9.8% year-over-year, from $29.28M to $26.4M.

What is the long-term trend for AtriCure's R&D?

Over 4 years (2021 to 2025), AtriCure's R&D has grown at a 19.6% compound annual growth rate (CAGR), from $48.51M to $99.21M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

AtriCure ATRC R&D

Discontinued — last reported Q2 '26

R&D at other companies

AbbottABT

$892M+23.0%

Johnson & JohnsonJNJ

$3.65B+3.9%

MedtronicMDT

$671M-1.9%

ITG

Integer HoldingsITGR

$16.24M+14.4%

AngioDynamicsANGO

$8.18M+24.1%

AVN

AVNSAVNS

$5.2M-3.7%

Other financials

Income statement

See full

Revenue$153.6M+12.8%

Gross profit$118.6M+16.9%

Operating income$9.7M+256%

Net income$9.0M+245%

EPS (diluted)$0.18+238%

Balance sheet

See full

Cash & equivalents$167.8M+42.4%

Total debt$75.5M-3.8%

Total equity$516.4M+11.2%

Total assets$676.6M+11.1%

Cash flow

See full

Operating cash flow$22.2M+2.7%

CapEx$3.8M+41.5%

Free cash flow$18.4M-2.8%

Valuation

See full

Market cap$1.89B+28.7%

Enterprise value$1.8B+26.0%

P/E726.2×—

P/S3.3×+0.4×

Profitability

See full

Gross margin76.3%+1.6pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.3%—

Returns & leverage

See full

Return on equity-6.1%-1.3pp

Debt / equity0.1×0.0×

Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: AtriCure’s 10-Q, filed July 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AtriCure's R&D?: AtriCure (ATRC) reported R&D of $26.4M in Q2 2026.
How has AtriCure's R&D changed year-over-year?: AtriCure's R&D decreased by 9.8% year-over-year, from $29.28M to $26.4M.
What is the long-term trend for AtriCure's R&D?: Over 4 years (2021 to 2025), AtriCure's R&D has grown at a 19.6% compound annual growth rate (CAGR), from $48.51M to $99.21M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.